BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1159 related articles for article (PubMed ID: 8931609)

  • 21. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
    Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
    Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer.
    Weir L; Speers C; D'yachkova Y; Olivotto IA
    J Clin Oncol; 2002 Apr; 20(7):1793-9. PubMed ID: 11919236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
    Diel IJ; Solomayer EF; Bastert G
    Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors.
    Gerber B; Krause A; Müller H; Richter D; Reimer T; Makovitzky J; Herrnring C; Jeschke U; Kundt G; Friese K
    J Clin Oncol; 2001 Feb; 19(4):960-71. PubMed ID: 11181658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
    Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
    J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
    van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
    Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
    Ma X; Yang X; Yang W; Shui R
    Sci Rep; 2021 May; 11(1):9534. PubMed ID: 33953240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
    Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
    Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is axillary dissection always indicated in invasive breast cancer?
    Chadha M; Axelrod D
    Oncology (Williston Park); 1997 Oct; 11(10):1463-8; discussion 1468, 1473-9. PubMed ID: 9348554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
    Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
    Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
    Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
    Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of bone marrow accumulation of Tc-99m tetrofosmin for subsequent development of distant metastases in breast cancer.
    Wakasugi S; Tsukuma H; Inaji H; Hashizume T; Noguchi A; Ohnishi T
    Ann Nucl Med; 2007 Oct; 21(8):429-37. PubMed ID: 17952551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators.
    Ravdin PM; De Laurentiis M; Vendely T; Clark GM
    J Natl Cancer Inst; 1994 Dec; 86(23):1771-5. PubMed ID: 7966415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.